As of 2025-05-20, the Intrinsic Value of Purple Biotech Ltd (PPBT.TA) is -6.90 USD. This PPBT.TA valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.20 USD, the upside of Purple Biotech Ltd is -264.25%.
Based on its market price of 4.20 USD and our intrinsic valuation, Purple Biotech Ltd (PPBT.TA) is overvalued by 264.25%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.90 - -6.90 | -6.90 | -264.25% |
| P/E | (7.45) - (11.98) | (9.73) | -331.6% |
| DDM - Stable | (12.51) - (38.34) | (25.43) | -705.4% |
| DDM - Multi | (10.97) - (26.61) | (15.59) | -471.2% |
| Market Cap (mil) | 22.04 |
| Beta | -0.23 |
| Outstanding shares (mil) | 5.25 |
| Enterprise Value (mil) | 14.82 |
| Market risk premium | 5.63% |
| Cost of Equity | 9.48% |
| Cost of Debt | 5.00% |
| WACC | 9.43% |